Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard Stock

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Prostate

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
79
Stone, Nelson
25
Cesaretti, Jamie A.
15
Lehrer, Steven
9
Rosenstein, Barry
8
Unger, Pamela
8
Diamond, Edward
7
Atencio, David
7
Lo, Yeh-Chi
7
Iannuzzi, Christopher
7
Dewyngaert, JK
6
Kao, Johnny
6
Green, Sheryl
6
Droller, Michael
4
Kollmeier, Marisa
3
Formenti, Silvia

Sign-in to see all Coauthors

Publications

TOP 3
Kao Johnny; Packer Stuart; Vu Ha Linh; Schwartz Myron E; Sung Max W; Stock Richard G; Lo Yeh-Chi; Huang Delphine; Chen Shu-Hsia; Cesaretti Jamie A
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.
Stock Richard G; Klein Thomas J; Cesaretti Jamie A; Stone Nelson N
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
Solan Amy N; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Stock (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kao Johnny; Packer Stuart; Vu Ha Linh; Schwartz Myron E; Sung Max W; Stock Richard G; Lo Yeh-Chi; Huang Delphine; Chen Shu-Hsia; Cesaretti Jamie A
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.
Cancer 2009;115(15):3571-80.
2009: Stock Richard G; Klein Thomas J; Cesaretti Jamie A; Stone Nelson N
Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy.
International journal of radiation oncology, biology, physics 2009;74(3):753-8.
2009: Solan Amy N; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(5):1468-74.
2009: Stone Nelson N; Potters Louis; Davis Brian J; Ciezki Jay P; Zelefsky Michael J; Roach Mack; Shinohara Katsuto; Fearn Paul A; Kattan Michael W; Stock Richard G
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(2):341-6.
2008: Stock Richard G
Counterpoint: High-risk prostate cancer: the case for combination brachytherapy and external beam irradiation.
Brachytherapy 2008;7(4):280-2; discussion 283.
2008: Lehrer Steven; Montazem André; Ramanathan Lakshmi; Pessin-Minsley Melissa; Pfail John; Stock Richard G; Kogan Rita
Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2008;106(3):389-91.
2008: Stock Richard G; Cesaretti Jamie A; Unger Pamela; Stone Nelson N
Distant and local recurrence in patients with biochemical failure after prostate brachytherapy.
Brachytherapy 2008;7(3):217-22.
2008: Peters Christopher A; Stock Richard G; Cesaretti Jamie A; Atencio David P; Peters Sheila; Burri Ryan J; Stone Nelson N; Ostrer Harry; Rosenstein Barry S
TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
International journal of radiation oncology, biology, physics 2008;70(3):752-9.
2008: Kao Johnny; Stone Nelson N; Lavaf Amir; Dumane Vishruta; Cesaretti Jamie A; Stock Richard G
(125)I monotherapy using D90 implant doses of 180 Gy or greater.
International journal of radiation oncology, biology, physics 2008;70(1):96-101.
2007: Ho Alice Y; Fan Grace; Atencio David P; Green Sheryl; Formenti Silvia C; Haffty Bruce G; Iyengar Preetha; Bernstein Jonine L; Stock Richard G; Cesaretti Jamie A; Rosenstein Barry S
Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy.
International journal of radiation oncology, biology, physics 2007;69(3):677-84.
2007: Cesaretti Jamie A; Stone Nelson N; Skouteris Vassilios M; Park Janelle L; Stock Richard G
Brachytherapy for the treatment of prostate cancer.
Cancer journal (Sudbury, Mass.) 2007;13(5):302-12.
2007: Cesaretti Jamie A; Kao Johnny; Stone Nelson N; Stock Richard G
Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up.
BJU international 2007;100(2):362-7.
2007: Cesaretti Jamie A; Stock Richard G; Atencio David P; Peters Sheila A; Peters Christopher A; Burri Ryan J; Stone Nelson N; Rosenstein Barry S
A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy.
International journal of radiation oncology, biology, physics 2007;68(5):1410-6.
2007: Stone Nelson N; Stock Richard G; White Ida; Unger Pam
Patterns of local failure following prostate brachytherapy.
The Journal of urology 2007;177(5):1759-63; duscussion 1763-4.
2007: Stone Nelson N; Stock Richard G
The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume.
The Journal of urology 2007;177(3):925-8.
2007: Stone Nelson N; Stock Richard G
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
Urology 2007;69(2):338-42.
2007: Ho Alice Y; Burri Ryan J; Jennings Glenn T; Stone Nelson N; Cesaretti Jamie A; Stock Richard G
Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer.
Brachytherapy 2007;6(1):38-43.
2007: Zagar Timothy M; Stock Richard G; Cesaretti Jamie A; Stone Nelson N
Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.
Brachytherapy 2007;6(1):26-33.
2006: Lehrer Steven; Cesaretti Jamie; Stone Nelson N; Stock Richard G
Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
BJU international 2006;98(5):979-81.
2006: Stock Richard G; Ho Alice; Cesaretti Jamie A; Stone Nelson N
Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control.
International journal of radiation oncology, biology, physics 2006;66(2):389-94.
2006: Peters Christopher A; Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease.
International journal of radiation oncology, biology, physics 2006;66(2):424-9.
2006: Ho Alice Y; Atencio David P; Peters Sheila; Stock Richard G; Formenti Silvia C; Cesaretti Jamie A; Green Sheryl; Haffty Bruce; Drumea Karen; Leitzin Larisa; Kuten Abraham; Azria David; Ozsahin Mahmut; Overgaard Jens; Andreassen Christian N; Trop Cynthia S; Park Janelle; Rosenstein Barry S
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
International journal of radiation oncology, biology, physics 2006;65(3):646-55.
2006: Andreassen Christian N; Overgaard Jens; Alsner Jan; Overgaard Marie; Herskind Carsten; Cesaretti Jamie A; Atencio David P; Green Sheryl; Formenti Silvia C; Stock Richard G; Rosenstein Barry S
ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.
International journal of radiation oncology, biology, physics 2006;64(3):776-83.
2006: Stock Richard G; Cesaretti Jamie A; Stone Nelson N
Disease-specific survival following the brachytherapy management of prostate cancer.
International journal of radiation oncology, biology, physics 2006;64(3):810-6.
2006: Stock Richard G; Stone Nelson N; Cesaretti Jamie A; Rosenstein Barry S
Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.
International journal of radiation oncology, biology, physics 2006;64(2):527-33.
2006: Stock Richard G
High-dose-rate versus low-dose-rate monotherapy in the treatment of localized prostate cancer: The case for low-dose-rate monotherapy.
Brachytherapy 2006;5(1):5-6; discussion 8.
2005: Lehrer Steven; Diamond Edward J; Stone Nelson N; Stock Richard G
Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer.
BJU international 2005;96(3):328-9.
2005: Stone Nelson N; Stock Richard G
Reduction of pulmonary migration of permanent interstitial sources in patients undergoing prostate brachytherapy.
Urology 2005;66(1):119-23.
2005: Lehrer Steven; Diamond Edward J; Mamkine Boris; Droller Michael J; Stone Nelson N; Stock Richard G
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
BJU international 2005;95(7):961-2.
2005: Kollmeier M A; Stock R G; Cesaretti J; Stone N N
Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
The Journal of urology 2005;173(3):808-12.
2005: Stone Nelson N; Stock Richard G; Unger Pam
Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer.
The Journal of urology 2005;173(3):803-7.
2005: Cesaretti Jamie A; Stock Richard G; Lehrer Steven; Atencio David A; Bernstein Jonine L; Stone Nelson N; Wallenstein Sylvan; Green Sheryl; Loeb Karen; Kollmeier Marisa; Smith Michael; Rosenstein Barry S
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
International journal of radiation oncology, biology, physics 2005;61(1):196-202.
2005: Lehrer Steven; Stone Nelson N; Stock Richard G
Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy.
The Journal of urology 2005;173(1):79-81.
2004: Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Does prior transurethral resection of prostate compromise brachytherapy quality: a dosimetric analysis.
International journal of radiation oncology, biology, physics 2004;60(2):648-53.
2004: Stock Richard G; Cahlon Oren; Cesaretti Jamie A; Kollmeier Marisa A; Stone Nelson N
Combined modality treatment in the management of high-risk prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(5):1352-9.
2003: Kollmeier Marisa A; Stock Richard G; Stone Nelson
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
International journal of radiation oncology, biology, physics 2003;57(3):645-53.
2003: Lehrer S; Roboz J; Ding H; Zhao S; Diamond E J; Holland J F; Stone N N; Droller M J; Stock R G
Putative protein markers in the sera of men with prostatic neoplasms.
BJU international 2003;92(3):223-5.
2003: Cesaretti Jamie A; Stone Nelson N; Stock Richard G
Urinary symptom flare following I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;56(4):1085-92.
2003: Stock Richard G; Stone Nelson N; Cesaretti Jamie A
Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.
International journal of radiation oncology, biology, physics 2003;56(2):448-53.
2003: Stone Nelson N; Stock Richard G
Practical considerations in permanent brachytherapy for localized adenocarcinoma of the prostate.
The Urologic clinics of North America 2003;30(2):351-62.
2003: Lehrer Steven; Diamond Edward J; Stone Nelson N; Droller Michael J; Stock Richard G; Stone Michelle; Bajwa Asghar; Kornreich Ruth
Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.
Urologic oncology 2003;21(2):101-4.
2003: Stone Nelson N; Stock Richard G
Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
Brachytherapy 2003;2(1):32-9.
2003: Stone Nelson N; Hong Suzanne; Lo Yeh-Chi; Howard Victor; Stock Richard G
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Brachytherapy 2003;2(1):17-25.
2003: Stock Richard G
The role of hormonal therapy in prostate brachytherapy. Point.
Brachytherapy 2003;2(1):1-2.
2002: Lehrer Steven; Diamond Edward J; Droller Michael J; Stone Nelson N; Stock Richard G
Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.
Journal of the National Cancer Institute 2002;94(24):1893; author reply 1893-4.
2002: Lehrer Steven; Diamond Edward J; Stone Nelson N; Droller Michael J; Stock Richard G
Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia.
The Journal of urology 2002;168(6):2431-3.
2002: Lehrer S; Diamond E J; Stagger S; Stone N N; Stock R G
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
British journal of cancer 2002;87(7):726-8.
2002: Stone Nelson N; Stock Richard G
Permanent seed implantation for localized adenocarcinoma of the prostate.
Current urology reports 2002;3(3):201-6.
2002: Stock Richard G; Stone Nelson N
Importance of post-implant dosimetry in permanent prostate brachytherapy.
European urology 2002;41(4):434-9.
2002: Stone N N; Stock R G
Complications following permanent prostate brachytherapy.
European urology 2002;41(4):427-33.
2002: Lehrer Steven; Stone Nelson N; Droller Michael J; Stock Richard G
Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer.
Urologic oncology 2002;7(2):73-6.
2002: Iannuzzi Christopher M; Atencio David P; Green Sheryl; Stock Richard G; Rosenstein Barry S
ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
International journal of radiation oncology, biology, physics 2002;52(3):606-13.
2002: Lee Lucille N; Stock Richard G; Stone Nelson N
Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation.
International journal of radiation oncology, biology, physics 2002;52(2):444-52.
2002: Lehrer Steven; Diamond Edward J; Stagger Sharodka; Stone Nelson N; Stock Richard G
Increased serum insulin associated with increased risk of prostate cancer recurrence.
The Prostate 2002;50(1):1-3.
2002: Stone Nelson N; Roy Jiten; Hong Suzanne; Lo Yeh-Chi; Stock Richard G
Prostate gland motion and deformation caused by needle placement during brachytherapy.
Brachytherapy 2002;1(3):154-60.
2002: Stock Richard G; Stone Nelson N
Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer.
Brachytherapy 2002;1(1):2-10.
2002: Stock Richard G; Stone Nelson N; Dahlal Mehud; Lo Yeh Chi
What is the optimal dose for 125I prostate implants? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term urinary symptoms.
Brachytherapy 2002;1(2):83-9.
2001: Snyder K M; Stock R G; Hong S M; Lo Y C; Stone N N
Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
International journal of radiation oncology, biology, physics 2001;50(2):335-41.
2001: Stock R G; Kao J; Stone N N
Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer.
The Journal of urology 2001;165(2):436-9.
2001: Atencio D P; Iannuzzi C M; Green S; Stock R G; Bernstein J L; Rosenstein B S
Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography.
Environmental and molecular mutagenesis 2001;38(2-3):200-8.
2000: Lehrer S; McCurdy L D; Stock R G; Kornreich R; Stone N N; Eng C
Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.
Cancer genetics and cytogenetics 2000;122(2):131-3.
2000: Stock R G; Stone N N; Kao J; Iannuzzi C; Unger P
The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization.
Cancer 2000;89(8):1829-34.
2000: Stock R G; Stone N N; Lo Y C; Malhado N; Kao J; DeWyngaert J K
Postimplant dosimetry for (125)I prostate implants: definitions and factors affecting outcome.
International journal of radiation oncology, biology, physics 2000;48(3):899-906.
2000: Fang D X; Stock R G; Stone N N; Krynyckyi B R; Kim C K; Machac J
Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy.
Techniques in urology 2000;6(2):146-50.
2000: Stone N N; Ratnow E R; Stock R G
Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation.
Techniques in urology 2000;6(2):123-7.
2000: Stone N N; Stock R G
Dynamic cystography can replace cystoscopy following prostate seed implantation.
Techniques in urology 2000;6(2):112-6.
2000: Stock R G; Stone N N; Lo Y C
Intraoperative dosimetric representation of the real-time ultrasound-guided prostate implant.
Techniques in urology 2000;6(2):95-8.
2000: Stone N N; Stock R G; Unger P; Kao J
Biopsy results after real-time ultrasound-guided transperineal implants for stage T1-T2 prostate cancer.
Journal of endourology / Endourological Society 2000;14(4):375-80.
2000: Stone N N; Stock R G
Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality.
International journal of radiation oncology, biology, physics 2000;46(5):1199-204.
2000: Stone N N; Stock R G; Unger P
Effects of neoadjuvant hormonal therapy on prostate biopsy results after (125)I and (103)Pd seed implantation.
Molecular urology 2000;4(3):163-8;discussion 169-70.
1999: Stock R G; Lo Y C; Gaildon M; Stone N N
Does prostate brachytherapy treat the seminal vesicles? A dose-volume histogram analysis of seminal vesicles in patients undergoing combined PD-103 prostate implantation and external beam irradiation.
International journal of radiation oncology, biology, physics 1999;45(2):385-9.
1999: Stone N N; Stock R G
Prostate brachytherapy: treatment strategies.
The Journal of urology 1999;162(2):421-6.
1999: Green S; Stock R G; Greenstein A J
Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy.
International journal of radiation oncology, biology, physics 1999;44(4):835-40.
1999: Stock R G; Stone N N
Permanent radioactive seed implantation in the treatment of prostate cancer.
Hematology/oncology clinics of North America 1999;13(3):489-501.
1999: Stone N N; Stock R G
Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
The Mount Sinai journal of medicine, New York 1999;66(1):26-30.
1999: Iannuzzi C M; Stock R G; Stone N N
PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer.
Radiation oncology investigations 1999;7(1):30-5.
1998: Stone N N; Stock R G; Parikh D; Yeghiayan P; Unger P
Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
The Journal of urology 1998;160(5):1722-6.
1998: Terk M D; Stock R G; Stone N N
Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.
The Journal of urology 1998;160(4):1379-82.
1998: Lehrer S; Fodor F; Stock R G; Stone N N; Eng C; Song H K; McGovern M
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
British journal of cancer 1998;78(6):771-3.
1998: Stock R G; Stone N N; Tabert A; Iannuzzi C; DeWyngaert J K
A dose-response study for I-125 prostate implants.
International journal of radiation oncology, biology, physics 1998;41(1):101-8.
1998: Desai J; Stock R G; Stone N N; Iannuzzi C; DeWyngaert J K
Acute urinary morbidity following I-125 interstitial implantation of the prostate gland.
Radiation oncology investigations 1998;6(3):135-41.
1997: Stock R G; Dottino P; Jennings T S; Terk M; DeWyngaert J K; Beddoe A M; Cohen C
Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
Gynecologic oncology 1997;67(3):309-15.
1997: Stock R G; Stone N N
The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy.
Seminars in surgical oncology 1997;13(6):454-60.
1997: Stone N N; Stock R G; Unger P
Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.
The Journal of urology 1997;158(5):1891-4.
1997: Stock R G; Chan K; Terk M; Dewyngaert J K; Stone N N; Dottino P
A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance.
International journal of radiation oncology, biology, physics 1997;37(4):819-25.
1996: Linzer D G; Stock R G; Stone N N; Ratnow R; Ianuzzi C; Unger P
Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer.
Urology 1996;48(5):757-61.
1996: Stock R G; Chen A S; Karasek K
Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
The cancer journal from Scientific American 1996;2(5):256-62.
1996: Stock R G; Stone N N; DeWyngaert J K; Lavagnini P; Unger P D
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Cancer 1996;77(11):2386-92.
1996: Stock R G; Stone N N; Iannuzzi C
Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
International journal of radiation oncology, biology, physics 1996;35(2):267-72.
1996: Glajchen N; Shapiro R D; Stock R G; Stone N N; Ramos R
CT findings after laparoscopic pelvic lymph node dissection and transperineal radioactive seed implantation for prostatic carcinoma.
AJR. American journal of roentgenology 1996;166(5):1165-8.
1995: Stock R G; Stone N N; Ianuzzi C; Unger P
Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
International journal of radiation oncology, biology, physics 1995;33(4):815-21.
1995: Stone N N; Stock R G; Unger P
Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate.
The Journal of urology 1995;154(4):1392-6.
1995: Stock R G
Locoregional therapies for early-stage prostate cancer.
Oncology (Williston Park, N.Y.) 1995;9(9):803-11; discussion 815-6.
1995: Stock R G; Stone N N; Wesson M F; DeWyngaert J K
A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation.
International journal of radiation oncology, biology, physics 1995;32(1):219-25.
1995: Stock R G; Chen A S; Flickinger J C; Kalnicki S; Seski J
Node-positive cervical cancer: impact of pelvic irradiation and patterns of failure.
International journal of radiation oncology, biology, physics 1995;31(1):31-6.
1995: Stock R G; Chen A S; Seski J
A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities.
Gynecologic oncology 1995;56(1):45-52.
1995: Stone N N; Stock R G
Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation.
Techniques in urology 1995;1(2):72-80.

Sign-in to see more